Time
|
Control
|
BM-MSCs
|
---|
Low-dose
|
High-dose
|
---|
6 months
|
−3 (−6, 0)
|
0 (−1, 0)
|
0 (−1, 1)
|
12 months
|
−4 (−18, 0)
|
0 (0, 3)
|
0 (−1, 2)
|
- For each group of treatment, variation for knee joint space width, which was measured in mm, was calculated by subtracting, for each patient of the group, the value at 6 or 12 months from the baseline value. Data are presented as the median (IQR) of each group